PROSTATE CANCER AGGRESSIVENESS
Clinical trials for PROSTATE CANCER AGGRESSIVENESS explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER AGGRESSIVENESS trials appear
Sign up with your email to follow new studies for PROSTATE CANCER AGGRESSIVENESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep aggressive prostate cancer in check
Disease control CompletedThis study tests whether the drug olaparib can help control aggressive variant prostate cancer when given after initial chemotherapy. About 96 men will receive cabazitaxel, carboplatin, and prednisone first, then either olaparib or observation. The goal is to see if olaparib exte…
Matched conditions: PROSTATE CANCER AGGRESSIVENESS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI learns from 14,000 prostate scans to spot aggressive cancers
Knowledge-focused CompletedThis study created a massive, secure database of over 14,000 prostate MRI scans from men with or suspected of having prostate cancer. Researchers used this data to train artificial intelligence (AI) models to better tell apart slow-growing from aggressive cancers, predict if canc…
Matched conditions: PROSTATE CANCER AGGRESSIVENESS
Sponsor: Fondazione del Piemonte per l'Oncologia • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC